Works by Mai, Hai‐Qiang

Results: 85
    1
    2
    3
    4
    5

    Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928214
    By:
    • Liu, Li-Ting;
    • Liang, Yu-Jing;
    • Guo, Shan-Shan;
    • Mo, Hao-Yuan;
    • Guo, Ling;
    • Wen, Yue-Feng;
    • Xie, Hao-Jun;
    • Tang, Qing-Nan;
    • Sun, Xue-Song;
    • Liu, Sai-Lan;
    • Li, Xiao-Yun;
    • Yang, Jin-Hao;
    • Yang, Zhen-Chong;
    • Tang, Lin-Quan;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    6
    7
    8

    Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5371, doi. 10.1007/s00520-021-06128-6
    By:
    • Duan, Yu-Yu;
    • Deng, Jun;
    • Su, Dong-Fang;
    • Li, Wen-Qiong;
    • Han, Yuan;
    • Li, Zhen-Xiu;
    • Huan, Xue-Zhen;
    • Zhu, Shi-Heng;
    • Yang, Qiu-Lan;
    • Hu, Wen;
    • Xin, Ming-Zhu;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang;
    • Fan, Yu-Ying;
    • He, Yan
    Publication type:
    Article
    9
    10
    11

    Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 12, p. e2138470, doi. 10.1001/jamanetworkopen.2021.38470
    By:
    • Tang, Qing-Nan;
    • Liu, Li-Ting;
    • Qi, Bin;
    • Guo, Shan-Shan;
    • Luo, Dong-Hua;
    • Sun, Rui;
    • Sun, Xue-Song;
    • Chen, Dong-Ping;
    • Guo, Ling;
    • Mo, Hao-Yuan;
    • Wang, Pan;
    • Liu, Sai-Lan;
    • Liang, Yu-Jing;
    • Li, Xiao-Yun;
    • Yang, Zhen-Chong;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang;
    • Tang, Lin-Quan
    Publication type:
    Article
    12

    Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup>F]‐fluorodeoxyglucose positron emission tomography

    Published in:
    Cancer Medicine, 2020, v. 9, n. 23, p. 8852, doi. 10.1002/cam4.3500
    By:
    • Xie, Hao‐Jun;
    • Yu, Yi‐Fei;
    • Sun, Xue‐Song;
    • Jia, Guo‐Dong;
    • Luo, Dong‐Hua;
    • Sun, Rui;
    • Liu, Li‐Ting;
    • Guo, Shan‐Shan;
    • Liu, Sai‐Lan;
    • Chen, Qiu‐Yan;
    • Tang, Lin‐Quan;
    • Mai, Hai‐Qiang
    Publication type:
    Article
    13
    14
    15

    Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 9, p. 4214, doi. 10.1002/cam4.2343
    By:
    • Sun, Xue‐Song;
    • Chen, Wen‐Hui;
    • Liu, Sai‐Lan;
    • Liang, Yu‐Jing;
    • Chen, Qiu‐Yan;
    • Guo, Shan‐Shan;
    • Wen, Yue‐Feng;
    • Liu, Li‐Ting;
    • Xie, Hao‐Jun;
    • Tang, Qing‐Nan;
    • Li, Xiao‐Yun;
    • Yan, Jin‐Jie;
    • Mai, Hai‐Qiang;
    • Tang, Lin‐Quan
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 8, p. 1294, doi. 10.1093/jnci/djae081
    By:
    • Lin, Da-Feng;
    • Li, Hai-Lin;
    • Liu, Ting;
    • Lv, Xiao-Fei;
    • Xie, Chuan-Miao;
    • Ou, Xiao-Min;
    • Guan, Jian;
    • Zhang, Ye;
    • Yan, Wen-Bin;
    • He, Mei-Lin;
    • Mao, Meng-Yuan;
    • Zhao, Xun;
    • Zhong, Lian-Zhen;
    • Chen, Wen-Hui;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang;
    • Peng, Rou-Jun;
    • Tian, Jie;
    • Tang, Lin-Quan;
    • Dong, Di
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x
    By:
    • Yuan, Li;
    • Jia, Guo-Dong;
    • Lv, Xiao-Fei;
    • Xie, Si-Yi;
    • Guo, Shan-Shan;
    • Lin, Da-Feng;
    • Liu, Li-Ting;
    • Luo, Dong-Hua;
    • Li, Yi-Fu;
    • Deng, Shen-Wen;
    • Guo, Ling;
    • Zeng, Mu-Sheng;
    • Cai, Xiu-Yu;
    • Liu, Sai-Lan;
    • Sun, Xue-Song;
    • Li, Xiao-Yun;
    • Li, Su-Chen;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    Relationship of circulating tumor cells and Epstein–Barr virus DNA to progression‐free survival and overall survival in metastatic nasopharyngeal carcinoma patients.

    Published in:
    International Journal of Cancer, 2019, v. 145, n. 10, p. 2873, doi. 10.1002/ijc.32380
    By:
    • You, Rui;
    • Liu, You‐Ping;
    • Lin, Mei;
    • Huang, Pei‐Yu;
    • Tang, Lin‐Quan;
    • Zhang, Yi‐Nuan;
    • Pan, Yi;
    • Liu, Wan‐Li;
    • Guo, Wei‐Bang;
    • Zou, Xiong;
    • Zhao, Ke‐Ming;
    • Kang, Ting;
    • Liu, Li‐Zhi;
    • Lin, Ai‐Hua;
    • Hong, Ming‐Huang;
    • Mai, Hai‐Qiang;
    • Zeng, Mu‐Sheng;
    • Chen, Ming‐Yuan
    Publication type:
    Article
    49
    50